Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (10084)	10/24/1997 1:58:00 PM
From: Sunny Jim	Read Replies (1) \| Respond to of 32384

Henry, LGND stock's behavior is quite puzzling given the announced deal with LLY. I am hoping that the mystery compound that LGND is going to select from LLY is what the market is holding out for. Out of everything in the deal with LLY, that item is the most puzzling because it is not well quantified. Is it worth millions in which case the dollar amount of the deal isn't fully reflecting it, or is it going to cost LGND millions to take it to market in which case the market may be viewing it as an asset with an attached liability? When that compound is announced or at least addressed more fully by Robinson, the market should react. Hopefully it is a positive reaction and we don't have to wait too long for it. I'm glad that there is a 90 day time limit on it. Long LGND,

To: Henry Niman who wrote (10084)	10/24/1997 4:47:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

Henry. I hate to say this.... But, after today's action on LGND, I think that we will need to prepare a new subject entitled: Ligand (LGND) Breakout 1998

To: Henry Niman who wrote (10084)	10/24/1997 8:35:00 PM
From: HB	Read Replies (1) \| Respond to of 32384

OFF TOPIC: Henry, do you have any thoughts on Pharmacyclics (PCYC) in this area? They are working on things for cancer phototherapy (in Phase II I believe) and atherosclerosis, among others.